Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.380
-0.050 (-1.46%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 975 employees as of December 31, 2025. The number of employees increased by 137 or 16.35% compared to the previous year.
Employees
975
Change (1Y)
137
Growth (1Y)
16.35%
Revenue / Employee
$270,258
Profits / Employee
-$401,003
Market Cap
1.39B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Agios Pharmaceuticals | 540 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Wave Life Sciences | 317 |
| Biohaven | 274 |
| Viridian Therapeutics | 252 |
| Precigen | 160 |
| Maze Therapeutics | 141 |
IOVA News
- 1 day ago - Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026 - GlobeNewsWire
- 11 days ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Iovance Biotherapeutics Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - What's Going On With Iovance Biotherapeutics Stock On Friday? - Benzinga
- 2 months ago - Iovance Biotherapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Iovance Biotherapeutics to Present at Upcoming Conferences - GlobeNewsWire
- 2 months ago - Iovance Biotherapeutics Explodes Over 20% — Early Trial Data Sparks Investor Frenzy - Benzinga
- 2 months ago - Iovance Biotherapeutics Earnings Call Transcript: Q4 2025 - Transcripts